HomeAnalyzeCompareBlog
← Blog

Is MercadoLibre Stock a Buy in 2026? MELI Analysis With Pros, Cons and Price Target

StocksAnalyzer·May 12, 2026·10 min read

Disclaimer: This article is for educational purposes only. It does not constitute financial advice or a recommendation to buy or sell. Investing in stocks involves risk of capital loss. Updated: May 12, 2026.

Short answer: MercadoLibre is the first case in our coverage with a "Consider Entry" signal. RSI at 29.3 indicates oversold conditions, the price is near 52-week lows and the lower Bollinger Band — a technical setup with potential for bounce. Fundamentals are acceptable (Health Score 60) with clear strengths (ROE 31.3%, revenue growth 38.3% and earnings growth 42.2%) but also real weaknesses: negative free cash flow, high debt (170% D/E) and immediate liquidity concerns. The median price target implies +44.6% upside and the 3-year Monte Carlo base scenario projects +8% to +171%. For long-term investors with emerging market risk tolerance, the data supports considering entry.

MercadoLibre is the absolute leader in e-commerce and digital payments in Latin America. It operates in Argentina, Brazil, Mexico, Chile, Colombia and other regional markets across five large verticals: Marketplace (e-commerce), Mercado Pago (payments and fintech), Mercado Envíos (logistics), Mercado Crédito (consumer credit) and Mercado Libre Ads (advertising). With a market cap of $78.4 billion and earnings expected August 5, the price of $1,546.81 — down -3.77% in today's session — raises a concrete question: is the recent correction an opportunity or a signal of something deeper?

Financial Health: 60 out of 100 — Acceptable With Lights and Shadows

MercadoLibre scores 60 out of 100 on the Health Score — an "Acceptable" rating. It is an intermediate score reflecting a mixed profile: exceptional return on capital and growth, but with real tensions in the balance sheet and cash generation. It is not the structural quality of Netflix (100) or Uber (100), but neither the fragility of Tesla (34).

MetricValueSignal
ROE31.3%Optimal
Profit Margin6.0%Low
Revenue Growth38.3%Optimal
Earnings Growth42.2%Optimal
Debt/Equity170%Watch
P/E Ratio40.8Watch
EV/EBITDA21.6Watch
Free Cash FlowNegativeWatch

The most relevant contrast in the profile is between growth and reported profitability. The 31.3% ROE confirms the business generates exceptional returns on invested capital. But the 6% net margin is low — it reflects the nature of a business aggressively reinvesting to scale new verticals (Payments, Logistics, Credit). Negative free cash flow is the consequence: the company is consuming cash to fuel growth.

Strengths and Weaknesses per Diagnostic

The diagnostic shows a more balanced profile of strengths and weaknesses than the Health Score suggests:

  • Strength — Exceptional ROE of 31.3%, well above the ideal 15% threshold
  • Strength — Revenue growth of 38.3%, among the highest in our coverage
  • Strength — Earnings growth of 42.2%, sustained profitability expansion
  • Weakness — P/E of 40.8x, possible overvaluation in absolute terms
  • Weakness — P/B of 10.77x, elevated premium to book value
  • Weakness — Negative free cash flow, consumes cash to grow
  • Weakness — EV/EBITDA of 21.6x, demanding enterprise valuation
  • Weakness — Low quick ratio, immediate liquidity risk
  • Weakness — Active bearish trend (Death Cross confirmed)

Valuation: Expensive in Absolute Terms, Reasonable on Growth

The diagnostic classifies the valuation as "expensive" relative to the market. The P/E of 40.8x is above the historical S&P 500 (20-22x). However, against 42.2% earnings growth, the implied PEG is below 1 — classically considered attractive. MELI's narrative is not that of a mature company optimizing margins; it is that of a dominant regional platform in full expansion mode, financed partially with debt and own cash.

  • P/E of 40.8x on earnings growth of 42.2% — PEG below 1 (attractive in PEG terms)
  • EV/EBITDA of 21.6x — demanding for a company with negative free cash flow
  • Debt/Equity of 170% — the highest in our coverage alongside AppLovin (172%)
  • Analyst median price target $2,236.28 — 44.6% upside, the highest in our coverage

Technical Signals: Oversold and Potential Bounce Zone

The technical picture is where MELI most clearly differentiates itself. RSI at 29.3 is below the classic oversold threshold (30), a historical signal of bearish move exhaustion. The price trades very close to the lower Bollinger Band and 52-week lows — everything stacks up as a potential bounce zone. The trend is classified as "moderately bearish" and the Death Cross remains active, which qualifies the read: there is a bounce setup but the underlying context has not yet reversed.

Annualized volatility of 39.2% is high. Key technical levels, with the price very close to support:

LevelPriceChange
Support$1,495.00-3.3%
Resistance 1$1,818.55+17.6%
Resistance 2$2,018.45+30.5%
Resistance 3$2,342.00+51.4%

Analyst Consensus: 84% Buy, +44.6% Upside

Of the 25 analysts covering MELI, 21 recommend buying (6 Strong Buy, 15 Buy), 4 hold and 0 sell. The 84% buy rate is one of the most favorable consensus readings in our coverage. The median price target is $2,236.28, with 44.6% upside — the highest of all the articles we have written. Importantly: even the lowest analyst target ($1,750) is +13% above the current price. There is not a single analyst who considers MELI to trade above fair value. Over the last 30 days: 0 upgrades, 3 downgrades — slightly negative revision momentum.

1–3 Month Monte Carlo Projections

With volatility at 39.2%, short-term ranges are wide. The proximity to support and oversold conditions shape the scenario:

ScenarioProbabilityRange
Optimistic25%+15.5% to +33.5% ($1,787 – $2,064)
Base50%-15.6% to +15.5% ($1,305 – $1,787)
Pessimistic25%-27.5% to -15.6% ($1,121 – $1,305)

The long-term profile (1–3 years) is notable: the optimistic scenario (40% probability) projects +171% to +296% ($4,191 – $6,120). The base scenario (45%) projects +8% to +171% ($1,667 – $4,191) — entirely in positive territory. The pessimistic (15%) projects -29% to +8% ($1,101 – $1,667). The combined probability of positive long-term returns is 85%, one of the most favorable asymmetries in our coverage, comparable to Netflix.

AI Signal: Consider Entry, Medium-High Confidence

StocksAnalyzer's AI assigns a "Consider Entry" signal with Medium-High confidence — the only direct entry signal in all our recent coverage (versus "Wait and Watch" for Netflix and Palantir, or "Avoid New Entries" for Tesla). The reasoning: acceptable fundamentals in active technical correction with multiple potential bounce indicators (oversold RSI, nearby support, lower Bollinger Band, 52-week low). The system recommends evaluating entry according to personal objectives, not dismissing it.

What to Watch Heading Into August 5 Earnings

  • Mercado Pago growth — the high-margin engine defining the profitability trajectory
  • Marketplace volume — the core metric of the legacy business, especially in Brazil and Mexico
  • Free cash flow trajectory — key for the valuation to be sustainable medium-term
  • Consumer credit portfolio — Mercado Crédito can be a growth lever or a risk factor depending on delinquency
  • Brazilian real and Argentine peso behavior — currency can amplify or moderate consolidated revenue in dollars

Frequently Asked Questions About MercadoLibre (MELI)

What does MercadoLibre do and why is it called the "Amazon of Latin America"?

MercadoLibre combines several businesses that in the U.S. exist in different companies. Marketplace (like Amazon), Mercado Pago (like PayPal), Mercado Envíos (own logistics), Mercado Crédito (financing) and Mercado Libre Ads (advertising). It operates in over 18 Latin American countries with absolute leadership in most. The Amazon comparison is valid in regional scale and platform model, but MELI has proportionally more fintech exposure.

Why is the signal "Consider Entry" if fundamentals are only "Acceptable"?

The signal integrates fundamentals, valuation and technicals. Fundamentals are acceptable (not perfect like Netflix, but with 38-42% growth that is exceptional). Valuation is expensive in absolute terms but reasonable on PEG. What tips the signal toward entry is the technicals: RSI 29.3 (oversold), price near 52-week lows, lower Bollinger Band and key support at -3.3%. The combination of acceptable fundamentals with technical oversold conditions is historically one of the entry points with the best risk/reward ratio.

Is MercadoLibre's 170% debt concerning?

Yes, it is one of the most relevant points to monitor. A Debt/Equity ratio of 170% is elevated, comparable to AppLovin (172%). Part is explained by Mercado Crédito activity — the consumer credit business operates with structural leverage. But negative free cash flow and a low quick ratio limit room for maneuver. If cash generation deteriorates further, balance sheet pressure increases. It is the most relevant short-to-medium-term risk factor.

What does negative free cash flow mean?

Negative free cash flow means the company consumes more cash than it generates from operations after investments. In MELI this reflects the aggressive expansion phase: it invests in logistics, expands Mercado Pago, finances credit portfolio. It is not necessarily bad in a growth company — Amazon spent years with negative FCF — but it requires access to external financing or cash reserves to sustain it. It is the factor that most limits the Health Score and the cash-flow-based valuation.

What is MercadoLibre's stock price target according to analysts?

The median price target from the 25 analysts covering MELI is $2,236.28 (+44.6% over the current price of $1,546.81). It is the highest upside of all the companies we have analyzed. The range runs from $1,750 (most conservative) to $2,800 (most bullish). Notably, not even the most bearish analyst places the target below the current price — something unusual and a reflection of the favorable consensus.

Where can I see the full, up-to-date MercadoLibre (MELI) analysis?

You can analyze MercadoLibre (MELI) for free at stocksanalyzer.app/analyze — enter the MELI ticker to get the health score, live RSI, volatility, Monte Carlo simulation and an AI signal with a clear buy/sell verdict.

Reference sources: SEC (U.S. Securities and Exchange Commission) — sec.gov | Damodaran Online, NYU Stern School of Business — pages.stern.nyu.edu/~adamodar | CFA Institute — cfainstitute.org

Written by the StocksAnalyzer team. Content reviewed and updated as of May 12, 2026. This article is for educational purposes only and does not constitute financial advice or investment recommendation.

Related articles

What is the Health Score and how to interpret it?

The Health Score is a 0-100 rating that summarizes a company's financial health in a single number.

Monte Carlo Projections: how to estimate a stock's future

Monte Carlo simulations don't predict the future, but they do show you the range of possible scenarios based on historical volatility.

RSI: the indicator every investor should know

The RSI measures whether a stock is overbought or oversold. We explain how to use it to make better decisions.